标题
Why hasn’t there been more progress in new Chagas disease drug discovery?
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume -, Issue -, Pages 1-14
出版商
Informa UK Limited
发表日期
2019-11-01
DOI
10.1080/17460441.2020.1681394
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chagas Cardiomyopathy in Latin America Review
- (2019) Jefferson Luis Vieira et al. Current Cardiology Reports
- Correction: Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis
- (2019) María A. Natale et al. PLoS Neglected Tropical Diseases
- Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity
- (2018) Bianca Zingales ACTA TROPICA
- From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases
- (2018) LEONARDO G. FERREIRA et al. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
- Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice
- (2018) Lívia de Figueiredo Diniz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Current advances in drug discovery for Chagas disease
- (2018) Cauê Benito Scarim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
- (2018) Faustino Torrico et al. LANCET INFECTIOUS DISEASES
- A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging
- (2018) Erica Silberstein et al. PLoS One
- Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review
- (2018) Cauê Benito Scarim et al. Revista da Sociedade Brasileira de Medicina Tropical
- A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
- (2018) Maan Zrein et al. PLoS Neglected Tropical Diseases
- The rise of neglected tropical diseases in the "new Texas"
- (2018) Peter J. Hotez PLoS Neglected Tropical Diseases
- Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis
- (2018) Lyda Z. Rojas et al. PLoS Neglected Tropical Diseases
- Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
- (2018) Lorna M. MacLean et al. PLoS Neglected Tropical Diseases
- Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure
- (2018) Fernando J Sánchez-Valdéz et al. eLife
- Innovation in neglected tropical disease drug discovery and development
- (2018) Hong-Bo Weng et al. Infectious Diseases of Poverty
- In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
- (2018) Raimunda S. S. Azevedo et al. Scientific Reports
- Is the priority review voucher program stimulating new drug development for tropical diseases?
- (2018) Kirk W. Kerr et al. PLoS Neglected Tropical Diseases
- Update on drug development targeting parasite cysteine proteases
- (2018) James H. McKerrow PLoS Neglected Tropical Diseases
- Alleviating the Neglected Tropical Diseases: Recent Developments in Diagnostics and Detection
- (2018) Satakshi Hazra et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- N-Nitrosulfonamides as Carbonic Anhydrase Inhibitors: A Promising Chemotype for Targeting Chagas Disease and Leishmaniasis
- (2018) Alessandro Bonardi et al. ACS Medicinal Chemistry Letters
- Advances on Aptamers against Protozoan Parasites
- (2018) Juan Ospina-Villa et al. Genes
- Drug Discovery for Kinetoplastid Diseases: Future Directions
- (2018) Srinivasa P. S. Rao et al. ACS Infectious Diseases
- Chagas disease
- (2018) Dan M. Tzizik et al. JAAPA-Journal of the American Academy of Physician Assistants
- Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening
- (2018) Cleber C. Melo-Filho et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phenotypic screening approaches for Chagas disease drug discovery
- (2017) Eric Chatelain et al. Expert Opinion on Drug Discovery
- Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi
- (2017) Alane Beatriz Vermelho et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers
- (2017) Carlos A. Morillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recently differentiated epimastigotes from Trypanosoma cruzi are infective to the mammalian host
- (2017) Rafael Luis Kessler et al. MOLECULAR MICROBIOLOGY
- Leishmania and other intracellular pathogens: selectivity, drug distribution and PK–PD
- (2017) SIMON L. CROFT PARASITOLOGY
- Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America
- (2017) Eloan Pinheiro et al. Revista da Sociedade Brasileira de Medicina Tropical
- Chagas disease research and development: Is there light at the end of the tunnel?
- (2017) Eric Chatelain Computational and Structural Biotechnology Journal
- Current drug therapy and pharmaceutical challenges for Chagas disease
- (2016) José Bermudez et al. ACTA TROPICA
- Progress Report on Neglected Tropical Disease Drug Donation Programs
- (2016) Joshua P. Cohen et al. CLINICAL THERAPEUTICS
- Advances in structure-based drug discovery of carbonic anhydrase inhibitors
- (2016) Claudiu T. Supuran Expert Opinion on Drug Discovery
- Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity
- (2016) Claudiu T Supuran Future Medicinal Chemistry
- Un modèle alternatif et innovant de Recherche et Développement pour garantir l’accès aux médicaments
- (2016) Bernard Pécoul M S-MEDECINE SCIENCES
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Autochthonous Transmission of Trypanosoma Cruzi in Southern California
- (2016) Salvador Hernandez et al. Open Forum Infectious Diseases
- Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly SensitiveIn VivoImaging
- (2015) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The use of posaconazole against Chagas disease
- (2015) Israel Molina et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
- (2015) Maria-Jesus Pinazo et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
- (2015) Bianca Zingales et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
- (2015) Carlos A. Morillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3highregulatory T cells in humans
- (2015) Makoto Miyara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Translational challenges of animal models in Chagas disease drug development: a review
- (2015) Eric Chatelain et al. Drug Design Development and Therapy
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
- (2015) Imanol Peña et al. Scientific Reports
- Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery
- (2015) Fernanda Fortes de Araujo et al. PLoS Neglected Tropical Diseases
- A Clinical Adverse Drug Reaction Prediction Model for Patients with Chagas Disease Treated with Benznidazole
- (2014) Gilberto Marcelo Sperandio da Silva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
- (2014) Maria T. Bahia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment
- (2014) Cynthia Santamaria et al. BMC INFECTIOUS DISEASES
- Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
- (2014) Bianca Zingales et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A Genome-Wide Analysis of Genetic Diversity in Trypanosoma cruzi Intergenic Regions
- (2014) Leonardo G. Panunzi et al. PLoS Neglected Tropical Diseases
- High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
- (2014) Julio Alonso-Padilla et al. PLoS Neglected Tropical Diseases
- Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice
- (2014) Rana Nagarkatti et al. PLoS Neglected Tropical Diseases
- In VitroandIn VivoStudies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi
- (2013) Maria de Nazaré Correia Soeiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease
- (2013) Peiwen Pan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review
- (2013) Ana Requena-Méndez et al. Expert Review of Anti-Infective Therapy
- New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
- (2013) J. M. Bustamante et al. JOURNAL OF INFECTIOUS DISEASES
- Cloning, Characterization, and Sulfonamide and Thiol Inhibition Studies of an α-Carbonic Anhydrase from Trypanosoma cruzi, the Causative Agent of Chagas Disease
- (2013) Peiwen Pan et al. JOURNAL OF MEDICINAL CHEMISTRY
- QSAR Modeling: Where Have You Been? Where Are You Going To?
- (2013) Artem Cherkasov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug rechallenge and treatment beyond progression—implications for drug resistance
- (2013) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- The ChEMBL bioactivity database: an update
- (2013) A. Patrícia Bento et al. NUCLEIC ACIDS RESEARCH
- Electrocardiographic Abnormalities in Trypanosoma cruzi Seropositive and Seronegative Former Blood Donors
- (2013) Antonio L. Ribeiro et al. PLoS Neglected Tropical Diseases
- Organ tropism during the acute and chronic phases of Trypanosoma cruzi infection in BALB/c mice
- (2012) LRC Oliveira et al. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
- Transgenic parasites accelerate drug discovery
- (2012) Ana Rodriguez et al. TRENDS IN PARASITOLOGY
- Fexinidazole: A Potential New Drug Candidate for Chagas Disease
- (2012) Maria Terezinha Bahia et al. PLoS Neglected Tropical Diseases
- Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR Approach
- (2012) Yvonne Qvarnstrom et al. PLoS Neglected Tropical Diseases
- The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications
- (2011) Bianca Zingales et al. INFECTION GENETICS AND EVOLUTION
- Interfering with pH regulation in tumours as a therapeutic strategy
- (2011) Dario Neri et al. NATURE REVIEWS DRUG DISCOVERY
- International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
- (2011) Alejandro G. Schijman et al. PLoS Neglected Tropical Diseases
- Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
- (2010) J. C. Engel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina
- (2009) Sergio Sosa-Estani et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?
- (2009) Yara M Gomes et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Two approaches to discovering and developing new drugs for Chagas disease
- (2009) JH McKerrow et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI
- (2009) B Zingales et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A new genotype of Trypanosoma cruzi associated with bats evidenced by phylogenetic analyses using SSU rDNA, cytochrome b and Histone H2B genes and genotyping based on ITS1 rDNA
- (2009) A. MARCILI et al. PARASITOLOGY
- Accidental infection by Trypanosoma cruzi follow-up by the polymerase chain reaction: case report
- (2009) Andréa Tieko Kinoshita-Yanaga et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity
- (2008) Claudiu T Supuran et al. EXPERT OPINION ON EMERGING DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search